BIOMAT Database Logo BIOMAT Database Logo

Evaluation of ototoxicity in children treated for retinoblastoma: preliminary results of a systematic audiological evaluation. 2011

Patricia Helena Pecora Liberman, and Christiane Schultz, and María Valéria Schmidt Goffi-Gómez, and Célia B G Antoneli, and Martha Motoro Chojniak, and Paulo Eduardo Novaes
Audiology Department, Hospital AC Camargo, Aclimação, Sao Paulo, Brazil. phpliberman@hcancer.org.br

BACKGROUND The objective of this study was to identify the ocurrence of hearing loss in children treated for retinoblastoma using a multidisciplinary approach. METHODS Thirty-two children were evaluated pre- and post-treatment. Eleven children were treated exclusively with enucleation, fifteen with carboplatin and six with cisplatin. Otoacoustic emissions were performed with the ILO 88, before and after the treatment. RESULTS In our study we found 5 children (24%) with hearing loss among the 21 evaluated. However in the group of children treated with carboplatin (N=15), 1 case (6.6%) presented hearing loss, while among those treated with cisplatin (N=6) we found 4 cases (66.6%) with hearing loss (p=0.0114). CONCLUSIONS We concluded that patients who are treated with cisplatin are at risk for developing hearing loss.

UI MeSH Term Description Entries
D008297 Male Males
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D004427 Ear Diseases Pathological processes of the ear, the hearing, and the equilibrium system of the body. Otologic Diseases,Otological Diseases,Disease, Ear,Disease, Otologic,Disease, Otological,Ear Disease,Otologic Disease,Otological Disease
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000158 Acoustic Impedance Tests Objective tests of middle ear function based on the difficulty (impedance) or ease (admittance) of sound flow through the middle ear. These include static impedance and dynamic impedance (i.e., tympanometry and impedance tests in conjunction with intra-aural muscle reflex elicitation). This term is used also for various components of impedance and admittance (e.g., compliance, conductance, reactance, resistance, susceptance). Audiometry, Impedance,Electroacoustic Impedance Tests,Impedance Tests, Acoustic,Tympanometry,Acoustic Impedance Test,Electroacoustic Impedance Test,Impedance Audiometry,Impedance Test, Acoustic,Impedance Test, Electroacoustic,Impedance Tests, Electroacoustic,Test, Acoustic Impedance,Test, Electroacoustic Impedance,Tests, Acoustic Impedance,Tests, Electroacoustic Impedance
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D001298 Audiology Allied medical specialty that studies hearing and hearing impairment.
D001299 Audiometry The testing of the acuity of the sense of hearing to determine the thresholds of the lowest intensity levels at which an individual can hear a set of tones. The frequencies between 125 and 8000 Hz are used to test air conduction thresholds and the frequencies between 250 and 4000 Hz are used to test bone conduction thresholds. Audiometries

Related Publications

Patricia Helena Pecora Liberman, and Christiane Schultz, and María Valéria Schmidt Goffi-Gómez, and Célia B G Antoneli, and Martha Motoro Chojniak, and Paulo Eduardo Novaes
[Audiological evaluation of ototoxicity in gentamycin-treated children (author's transl)].
September 1978, Wiener klinische Wochenschrift,
Patricia Helena Pecora Liberman, and Christiane Schultz, and María Valéria Schmidt Goffi-Gómez, and Célia B G Antoneli, and Martha Motoro Chojniak, and Paulo Eduardo Novaes
Audiological screening of school children--preliminary results.
January 1983, Scandinavian audiology. Supplementum,
Patricia Helena Pecora Liberman, and Christiane Schultz, and María Valéria Schmidt Goffi-Gómez, and Célia B G Antoneli, and Martha Motoro Chojniak, and Paulo Eduardo Novaes
Visual results in children treated for retinoblastoma.
March 2002, Eye (London, England),
Patricia Helena Pecora Liberman, and Christiane Schultz, and María Valéria Schmidt Goffi-Gómez, and Célia B G Antoneli, and Martha Motoro Chojniak, and Paulo Eduardo Novaes
Visual results in children treated for macular retinoblastoma.
January 2002, Eye (London, England),
Patricia Helena Pecora Liberman, and Christiane Schultz, and María Valéria Schmidt Goffi-Gómez, and Célia B G Antoneli, and Martha Motoro Chojniak, and Paulo Eduardo Novaes
Carboplatin-associated ototoxicity in children with retinoblastoma.
April 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
Patricia Helena Pecora Liberman, and Christiane Schultz, and María Valéria Schmidt Goffi-Gómez, and Célia B G Antoneli, and Martha Motoro Chojniak, and Paulo Eduardo Novaes
[Critical evaluation of the audiological test results in children].
January 1999, Otolaryngologia polska = The Polish otolaryngology,
Patricia Helena Pecora Liberman, and Christiane Schultz, and María Valéria Schmidt Goffi-Gómez, and Célia B G Antoneli, and Martha Motoro Chojniak, and Paulo Eduardo Novaes
Monitoring of ototoxicity in young children receiving carboplatin for retinoblastoma.
December 2009, Pediatric blood & cancer,
Patricia Helena Pecora Liberman, and Christiane Schultz, and María Valéria Schmidt Goffi-Gómez, and Célia B G Antoneli, and Martha Motoro Chojniak, and Paulo Eduardo Novaes
Ototoxicity in children treated for osteosarcoma.
March 2009, Pediatric blood & cancer,
Patricia Helena Pecora Liberman, and Christiane Schultz, and María Valéria Schmidt Goffi-Gómez, and Célia B G Antoneli, and Martha Motoro Chojniak, and Paulo Eduardo Novaes
Peripheral neuropathy and ototoxicity of dichlorodiamineplatinum: instrumental evaluation. Preliminary results.
October 1986, Gynecologic oncology,
Patricia Helena Pecora Liberman, and Christiane Schultz, and María Valéria Schmidt Goffi-Gómez, and Célia B G Antoneli, and Martha Motoro Chojniak, and Paulo Eduardo Novaes
Clinical and genetic associations for carboplatin-related ototoxicity in children treated for retinoblastoma: A retrospective noncomparative single-institute experience.
May 2018, Pediatric blood & cancer,
Copied contents to your clipboard!